NCT05064358 Study to Investigate Alternative Dosing Regimens of Belantamab Mafodotin in Participants With Relapsed or Refractory Multiple Myeloma Status COMPLETED Phase PHASE2
NCT05060432 Study of EOS-448 With Standard of Care and/or Investigational Therapies in Participants With Advanced Solid Tumors Status ACTIVE_NOT_RECRUITING Phase PHASE1/PHASE2
NCT05059301 A Study of 3 Lots of an Investigational Vaccine Against Respiratory Syncytial Virus (RSV) in Adults Aged 60 Years and Above Status COMPLETED Phase PHASE3
NCT05047770 A Study on the Immune Response and Safety of the Shingles Vaccine and the Influenza Vaccine When Either is Given to Healthy Adults at the Same Time or Following a COVID-19 Booster Vaccine Status COMPLETED Phase PHASE3
NCT05045144 A Phase III Study to Assess the Lot-to-lot Consistency of GSK's Investigational RSV Maternal Vaccine and the Immune Response and Safety of RSV Maternal Vaccine When Given Alone or Co-administered With GSK's Influenza D-QIV Vaccine in Healthy Non-pregnant Women. Status COMPLETED Phase PHASE3
NCT05044325 A First Time in Human (FTIH) Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single and Repeat Doses of GSK3884464 in Healthy Participants Status TERMINATED Phase PHASE1
NCT05007951 Immunogenicity and Safety Study of SK SARS-CoV-2 Recombinant Nanoparticle Vaccine (GBP510) Adjuvanted With AS03 (COVID-19) Status COMPLETED Phase PHASE3
NCT05002816 Novel Combination of Belantamab Mafodotin and Elotuzumab to Enhance Therapeutic Efficacy in Multiple Myeloma Status ACTIVE_NOT_RECRUITING Phase PHASE1/PHASE2
NCT04988152 A Study to Investigate the PK, Safety, and Tolerability of Sotrovimab vs Placebo Administered IV or IM in Japanese and Caucasian Participants Status COMPLETED Phase PHASE1
NCT04980391 A Study on the Safety and Immune Response to an Unadjuvanted RSV Maternal Vaccine, in High Risk Pregnant Women Aged 15 to 49 Years and Infants Born to the Vaccinated Mothers Status TERMINATED Phase PHASE3
NCT04975438 Clinical Effect, Safety and Tolerability of GSK1070806 in Atopic Dermatitis Status COMPLETED Phase PHASE1
NCT04971928 Phase 1 Study of GSK3228836 Pharmacokinetics in Participants With Hepatic Impairment Status COMPLETED Phase PHASE1
NCT04971590 Study to Assess Demographic, Pharmacologic, Biomarker, Clinical Features and Quality of Life (QoL) of Participants With Lupus Nephritis Status COMPLETED Phase N/A
NCT04965636 Study in Pediatrics With HypEREosinophilic Syndrome (SPHERE) Status COMPLETED Phase PHASE3
NCT04964050 A Bioequivalence Study Between Capozide Versus ACE-Hemmer-ratiopharm in Healthy Adult Participants Under Fasting Conditions Status WITHDRAWN Phase PHASE1
NCT04959344 Safety and Immunogenicity of a Klebsiella Pneumoniae Tetravalent Bioconjugate Vaccine (Kleb4V) Status COMPLETED Phase PHASE1/PHASE2